These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 17897079)

  • 1. Recent progress in the pharmacology of imidazo[1,2-a]pyridines.
    Enguehard-Gueiffier C; Gueiffier A
    Mini Rev Med Chem; 2007 Sep; 7(9):888-99. PubMed ID: 17897079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicinal Attributes of Imidazo[1,2-a]pyridine Derivatives: An Update.
    Devi N; Singh D; Rawal RK; Bariwal J; Singh V
    Curr Top Med Chem; 2016; 16(26):2963-2994. PubMed ID: 27150367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of diaryl-substituted imidazo[l,2-a]pyridines designed as potential aromatase inhibitors.
    Enguehard C; Renou JL; Allouchi H; Leger JM; Gueiffier A
    Chem Pharm Bull (Tokyo); 2000 Jul; 48(7):935-40. PubMed ID: 10923819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functionalized 3-amino-imidazo[1,2-a]pyridines: a novel class of drug-like Mycobacterium tuberculosis glutamine synthetase inhibitors.
    Odell LR; Nilsson MT; Gising J; Lagerlund O; Muthas D; Nordqvist A; Karlén A; Larhed M
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4790-3. PubMed ID: 19560924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological Potential and Synthetic Approaches of Imidazo[4,5-b]pyridine and Imidazo[4,5-c]pyridine Derivatives.
    Krause M; Foks H; Gobis K
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28273868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and SAR of Novel and Selective Inhibitors of Urokinase Plasminogen Activator (uPA) with an Imidazo[1,2-a]pyridine Scaffold.
    Gladysz R; Adriaenssens Y; De Winter H; Joossens J; Lambeir AM; Augustyns K; Van der Veken P
    J Med Chem; 2015 Dec; 58(23):9238-57. PubMed ID: 26575094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyridines and Imidazopyridines with Medicinal Significance.
    Kishbaugh TL
    Curr Top Med Chem; 2016; 16(28):3274-3302. PubMed ID: 27150370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IRAK-4 inhibitors. Part II: a structure-based assessment of imidazo[1,2-a]pyridine binding.
    Buckley GM; Ceska TA; Fraser JL; Gowers L; Groom CR; Higueruelo AP; Jenkins K; Mack SR; Morgan T; Parry DM; Pitt WR; Rausch O; Richard MD; Sabin V
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3291-5. PubMed ID: 18482836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (1H-imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: further optimisation as highly potent and selective MSK-1-inhibitors.
    Bamford MJ; Bailey N; Davies S; Dean DK; Francis L; Panchal TA; Parr CA; Sehmi S; Steadman JG; Takle AK; Townsend JT; Wilson DM
    Bioorg Med Chem Lett; 2005 Jul; 15(14):3407-11. PubMed ID: 15955699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imidazo[1,2-a]pyridine Scaffold as Prospective Therapeutic Agents.
    Deep A; Bhatia RK; Kaur R; Kumar S; Jain UK; Singh H; Batra S; Kaushik D; Deb PK
    Curr Top Med Chem; 2017; 17(2):238-250. PubMed ID: 27237332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and Evaluation of Imidazo[1,2-a]pyridine Analogues of the ZSTK474 Class of Phosphatidylinositol 3-Kinase Inhibitors.
    Gamage SA; Spicer JA; Tsang KY; O'Connor PD; Flanagan JU; Lee WJ; Dickson JMJ; Shepherd PR; Denny WA; Rewcastle GW
    Chem Asian J; 2019 Apr; 14(8):1249-1261. PubMed ID: 30714356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imidazopyridine-based selective and multifunctional ligands of biological targets associated with psychiatric and neurodegenerative diseases.
    Vanda D; Zajdel P; Soural M
    Eur J Med Chem; 2019 Nov; 181():111569. PubMed ID: 31404862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imidazo[1,2-a]Pyridine-3-Carboxamides Are Active Antimicrobial Agents against Mycobacterium avium Infection In Vivo.
    Moraski GC; Cheng Y; Cho S; Cramer JW; Godfrey A; Masquelin T; Franzblau SG; Miller MJ; Schorey J
    Antimicrob Agents Chemother; 2016 Aug; 60(8):5018-22. PubMed ID: 27216051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imidazo[1,2-a]pyridines: Promising Drug Candidate for Antitumor Therapy.
    Goel R; Luxami V; Paul K
    Curr Top Med Chem; 2016; 16(30):3590-3616. PubMed ID: 27086790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imidazo[1,2-a]pyridines. Part 2: SAR and optimisation of a potent and selective class of cyclin-dependent kinase inhibitors.
    Byth KF; Culshaw JD; Green S; Oakes SE; Thomas AP
    Bioorg Med Chem Lett; 2004 May; 14(9):2245-8. PubMed ID: 15081017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imidazo[4,5-
    Jarmoni K; Misbahi K; Ferrières V
    Curr Med Chem; 2024; 31(5):515-528. PubMed ID: 37170991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel solvent-free approach to imidazole containing nitrogen-bridgehead heterocycles.
    Attanasi OA; Bianchi L; Campisi LA; De Crescentini L; Favi G; Mantellini F
    Org Lett; 2013 Jul; 15(14):3646-9. PubMed ID: 23805986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosidase inhibitors and their chemotherapeutic value, Part 2.
    el Ashry ES; Rashed N; Shobier AH
    Pharmazie; 2000 May; 55(5):331-48. PubMed ID: 11828612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminoimidazo[1,2-a]pyridines as a new structural class of cyclin-dependent kinase inhibitors. Part 1: Design, synthesis, and biological evaluation.
    Jaramillo C; de Diego JE; Hamdouchi C; Collins E; Keyser H; Sánchez-Martínez C; del Prado M; Norman B; Brooks HB; Watkins SA; Spencer CD; Dempsey JA; Anderson BD; Campbell RM; Leggett T; Patel B; Schultz RM; Espinosa J; Vieth M; Zhang F; Timm DE
    Bioorg Med Chem Lett; 2004 Dec; 14(24):6095-9. PubMed ID: 15546737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel non-sulfonamide 5-HT
    Vanda D; Soural M; Canale V; Chaumont-Dubel S; Satała G; Kos T; Funk P; Fülöpová V; Lemrová B; Koczurkiewicz P; Pękala E; Bojarski AJ; Popik P; Marin P; Zajdel P
    Eur J Med Chem; 2018 Jan; 144():716-729. PubMed ID: 29291439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.